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Abstract Bacterial lipopolysaccharides (LPS) are potent
inducers of proinflammatory signaling pathways via the
activation of nuclear factor-kappa B (NF-κB) and mitogen-
activated protein kinase (MAPK), causing changes in the
processes that control lung fluid homeostasis and contrib-
uting to the pathogenesis of lung disease. In human H441
airway epithelial cells, incubation of cells with 15 µg ml−1
LPS caused a significant reduction in amiloride-sensitive Isc
from 15±2 to 8±2 µA cm−2 (p=0.01, n=13) and a shift in
IC50 amiloride of currents from 6.8×10
−7 to 6.4×10−6 M.
This effect was associated with a decrease in the activity of
5 pS, highly Na+ selective, amiloride-sensitive <1 µM
channels (HSC) and an increase in the activity of ∼18 pS,
nonselective, amiloride-sensitive >10 µM cation channels
(NSC) in the apical membrane. LPS decreased αENaC
mRNA and protein abundance, inferring that LPS inhibited
αENaC gene expression. This correlated with the decrease
in HSC activity, indicating that these channels, but not
NSCs, were comprised of at least αENaC protein. LPS
increased NF-κB DNA binding activity and phosphoryla-
tion of extracellular signal-related kinase (ERK)1/2, but
decreased phosphorylation of ERK5 in H441 cells. Pre-
treatment of monolayers with PD98059 (20 µM) inhibited
ERK1/2 phosphorylation, promoted phosphorylation of
ERK5, increased αENaC protein abundance, and reversed
the effect of LPS on Isc and the shift in amiloride sensitivity.
Inhibitors of NF-κB activation were without effect. Taken
together, our data indicate that LPS acts via ERK signaling
pathways to decrease αENaC transcription, reducing HSC/
ENaC channel abundance, activity, and transepithelial Na+
transport in H441 airway epithelial cells.
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Introduction
In lung disease states, particularly cystic fibrosis, Pseudo-
monas aeruginosa is a common opportunistic pathogen
which can cause exacerbation of the existing condition.
Such infections can lead to inflammation and damage to the
epithelial barrier. This can result in increased fluid leak
from the underlying tissues into the lumen of the conduct-
ing airways and the distal alveoli contributing to the
formation of pulmonary edema. Evidence has indicated
that bacterial and viral infections also modify the ion
transport processes that control lung fluid homeostasis [30,
43]. These processes maintain the correct hydration of the
luminal surface of the airway for optimal function of the
mucociliary escalator as part of the airway defense against
infection and the alveolar surface to maintain efficient gas
exchange. The vectorial transport of Na+ across the lung
epithelium via amiloride-sensitive epithelial Na+ channels
drives the osmotic movement of fluid from the lumen to the
interstitium. Two populations of amiloride-sensitive Na+-
permeable cation channels have been described in the
membrane of human H441 airway epithelial cells, alveolar
type I and type II cells that could contribute to apical Na+
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conductance (GNa+) [1, 8, 27, 28, 31] and these have been
described as a highly Na+ selective of 5 pS conductance
channel that is inhibited by <1 µM amiloride (HSC) and a
nonselective cation channel of ∼18 pS conductance that is
inhibited by >10 µM amiloride (NSC). The relative
expression of these channels in alveolar type II are
determined by culture conditions and the cellular abun-
dance of protein subunits of the epithelial Na+ channel
(ENaC) [6, 27, 31]. The HSC is thought to comprise
αENaC, βENaC, and γENaC in heterotrimeric combina-
tion, while the NSC has been reported to require only
αENaC. As these channels are essential for the regulation
of lung fluid homeostasis, then factors that alter their
expression and function could potentially lead to a decrease
in net fluid absorption and contribute to aberrant fluid
homeostasis in the airway and the formation of pulmonary
edema in the distal lung.
Lipopolysaccharide (LPS) present in the coat proteins of
many bacterial pathogens including P. aeruginosa are
potent inducers of the secretion and synthesis of proin-
flammatory cytokines such as TNF-α, reactive oxygen
species, and NO production via the activation of nuclear
factor-kappa B (NF-κB) and mitogen-activated protein
kinase (MAPK) signaling pathways [19, 20]. While the
release of factors into the medium by LPS-stimulated
alveolar macrophages has been shown to inhibit ENaC
expression in fetal distal lung epithelial cells via a NO-
dependent mechanism [13] and TNF-α has been demon-
strated to decrease ENaC mRNA expression in adult rat
alveolar epithelial cells [9, 10], the effects of LPS applied
directly to airway epithelial cells have not been fully
explored. In this paper, we have used the human H441
airway epithelial cell line, which has Clara cell-like
properties, to show that LPS inhibits amiloride-sensitive
Na+ transport and alters the amiloride sensitivity of the
monolayer by reducing the function of HSCs in the apical
membrane. We have also used a combination of pharma-
cological and molecular techniques to characterize the role
of NF-κB and the extracellular signal-regulated protein
kinases 1, 2, and 5 (ERK1, ERK2, and ERK5) in these
LPS-mediated effects.
Materials and methods
Cell culture
H441 cells (obtained from ATCC, USA) were grown in
RPMI 1640 medium (Life Technologies, UK) supple-
mented with 2 mM L-glutamine, sodium pyruvate, 10%
(v/v) fetal bovine serum (Immune Systems, UK) and
antibiotics (penicillin/streptomycin; Life Technologies,
UK). Cells were maintained at 37°C in humidified
atmospheric air +5% CO2 and passaged twice weekly. To
obtain resistive monolayers, H441 cells were seeded onto
snapwell clear membranes (Costar, UK) at 1×106 cells per
square centimeter and cultured overnight using the medium
described above. The following day, the medium was
replaced with RPMI 1640 medium including 4% dialyzed
fetal bovine serum, 2 mM L-glutamine, sodium pyruvate,
5 µg ml−1 insulin, 5 µg ml−1 transferrin, 10 nM sodium
selenite, 100 nM dexamethasone, and 10 nM triiodo-L-
thyronine (T3) and the cells were cultured at air interface
for 6–7 days. Cells with a transepithelial resistance (Rt) of
>200 Ω cm−2 were used in this study. Treatments were
carried out using a strictly paired protocol. LPS from P.
aeruginosa (Sigma, UK) was suspended in culture medium
and used at a final concentration of 15 µg ml−1 in the
basolateral compartment and 50 µl of LPS solution or
normal medium was dropped carefully onto the apical
surfaces of cells grown at air interface. This concentration
of LPS evoked a maximal change in transcriptional activity
of an NF-κB-driven reporter construct in these cells (data
not shown) and was similar to that used in other lung
studies [12]. Cells were pretreated with vehicle or MAPK
inhibitor (PD98059) 20 µM (a concentration which effec-
tively inhibited ERK1/2 phosphorylation in these cells) [34]
or caffeic acid phenyl ester (CAPE) 25 µg ml−1 in dimethyl
sulfoxide [39] or sulfasalazine (SAS; Sigma, UK) 5 mM
in culture medium [3, 21] for 30 min prior to the addition
of LPS.
Functional studies
Snapwells supporting resistive monolayers of H441 cells
were mounted in Ussing chambers and bathed with a
physiological salt solution (in millimolars): NaCl, 117;
NaHCO3, 25, KCl, 4.7; MgSO4, 1.2; KH2PO4, 1.2; CaCl2,
2.5; D-glucose, 11; pH 7.3–7.4 when equilibrated with 5%
CO2. The solution was maintained at 37°C and continu-
ously circulated by bubbling with 21% O2+5% CO2
premixed gas. The monolayers were firstly maintained
under open circuit conditions, while the transepithelial
potential difference (Vt) and resistance (Rt) were monitored
and observed to reach a stable level. The cells were then
short circuited by clamping Vt at 0 mV using a DVC-4000
voltage/current clamp (WPI, UK), and the current required
to maintain this condition (Isc) was measured and recorded
using a PowerLab computer interface. The movement of
cations from the apical to the basolateral side or anions
from the basolateral to apical side of the monolayer is
represented by positive values for Isc. Amiloride hydro-
chloride was suspended in H2O and used at concentrations
ranging from 10−4 to 10−10 M. Ouabain was resuspended in
50:50 ethanol/H2O and used at a final concentration of
10−3 M.
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Single-cation channel currents were recorded from H441
cell monolayers with an AXOpatch 200B patch clamp
amplifier (Axon Instruments, Union City, CA, USA) at
room temperature (20–25°C) using the cell-attached con-
figuration of the patch clamp technique as previously
described [1]. To set the membrane potential at approxi-
mately 0 mV, H441 monolayer cells were perfused with a
bathing solution containing (in millimolars): KCl, 145;
CaCl2, 1.8; MgCl2, 2; glucose, 5.5; and HEPES, 10; pH to
7.4 with KOH. The standard patch pipette solution
contained (in millimolars): NaCl, 145; CaCl2, 1.8; MgCl2,
2; glucose, 5.5; and HEPES, 10; pH to 7.4 with NaOH, and
with this solution, patch pipette resistances were 10–15 MΩ.
To investigate the amiloride sensitivity of cation channel
activity, 1 or 10 µM amiloride was included in the standard
patch pipette solution. Cation channel currents were recorded
and analyzed using pCLAMP software (version 9.0, Axon
Instruments) whereby channel activity was sampled at
between 1 and 2 kHz and low-pass filtered between 100 and
200 Hz and then idealized channel openings were created
using a 50% threshold method. Open times <3.332–6.664 ms
(2× rise time of low-pass filter) were excluded to reduce
the number of channel currents not reaching full
amplitude. The amplitude of single-channel currents,
open probability (NPo), and permeability ratios of
amiloride-sensitive channels in H441 cells were previously
described by Albert et al. [1].
RNA isolation and Northern blotting
Cells were lysed directly in TRI reagent (Genetic Research
Instrumentation, Baintree, UK). RNAwas prepared according
to the manufacturer’s instructions. Total RNA was
resuspended in RNase-free H2O and quantified by
analysis of optical density (OD) at 260λ by UV spectro-
photometry. For the northern analysis, 20 µg of denatured
total RNA was loaded onto formaldehyde gels (1.0%
agarose, 2.2 M formaldehyde in 3-(N-morpholino)pro-
panesulfonic acid [MOPS] buffer), electrophoresed in
MOPS buffer at 1 V cm−1 for 3–4 h, then transferred to
a nylon membrane (Amersham Biosciences, Bucks, UK) by
an electrophoretic transfer system (Amersham) and cross-
linked with an ultraviolet cross-linker (UVP, Upland, CA,
USA) as previously described [18].
αENaC, βENaC, and γENaC probes were prepared by
reverse transcription polymerase chain reaction. The sense
and antisense primers correspond to bases 1,059–1,079 and
1,802–1,822 of rat αENaC (GenBank accession no.
X70497), 880–900 and 1,232–1,252 of rat βENaC (Gen-
Bank accession no. X77932), and rat γENaC (GenBank
accession no. X77933). An 18S oligonucleotide probe was
used to correct for any loading variance between samples as
previously described [18]. The αENaC cDNA was ampli-
fied by polymerase chain reaction and the resultant product
was labeled with [α-32P]dCTP by random priming with
“Ready-to-Go” labeling beads (Amersham). Membranes
were prehybridized at 42°C for 30 min in Ultrahyb
(Ambion, Abingdon, UK). Hybridizations were carried
out overnight at 42°C. The blots were then washed to high
stringency in 0.05× saline–sodium citrate + 0.1% sodium
dodecyl sulfate (SDS) at 42°C and then were linearized by
restriction digestion with SacI and NcoI, respectively.
Antisense riboprobes incorporating [α-32P]CTP were
generated from the linearized βENaC and γENaC cDNA
templates using T7 RNA polymerase and SP6 polymerase,
respectively. The 18S deoxyoligonucleotide probe terminal
phosphate was replaced with 32P-γATP using polynucleo-
tide kinase (Promega, UK). Prehybridization, hybridization,
and washes were carried out as described above but at a
higher temperature of 68°C for these probes.
Western blots
For analysis of αENaC, phosphorylated ERK1, ERK2,
ERK5, and β-actin abundance, protein was prepared from
H441 cells by scraping cells into an ice-cold solution of tissue
lysis buffer (100 mM Tris pH 6.8, 1 mM ethylenediaminete-
traacetic acid pH 8.0, 10% v/v glycerol, and 10 µl ml−1
protease inhibitor cocktail; Sigma, UK). Cells were disrupted
by dounce homogenization and subjected to centrifugation
(5 min, 250×g) to remove nuclei. Biotinylation and
extraction of apical membrane proteins was performed as
previously described [33, 49]. Nuclear protein was extracted
as previously described [3]. For Western blotting, the
supernatants from each preparation were heated to 94°C for
5 min in the presence of 100 mM DTT and 2% w/v SDS to
denature the proteins. Samples containing 30 µg of protein
were subjected to electrophoresis on SDS–polyacrylamide
gels. Fractionated proteins were transferred to nitrocellulose
membranes by electroblotting and immunostained with anti-
αENaC antiserum N-terminal (Abcam, Cambridge, UK) or
C-terminal (Santa Cruz Biotech, USA), phospho-ERK1/2
(New England Biolabs, USA) or phospho-ERK5 (Cell
Signaling Technology, USA) using standard techniques.
Anti-β-actin monoclonal antiserum (Sigma, UK) was used
to assess protein loading. Immunostained proteins were
visualized by enhanced chemiluminescence (Amersham
ECL, Amersham, UK) and exposure to autoradiographic
film. Electromobility shift assays were conducted using
nuclear extracted protein or p50/p65 NF-κB protein (50 ng)
and double-stranded oligonucleotide probes containing the
human αENaC NF-κB consensus sequence 5′-ACACTTGG
GACTCCCCCCTT-3′ or missense sequences as previously
described [3]. Preincubation of nuclear extract with p50/p65
NF-κB antiserum (Cell Signaling Technology, USA) was
used to confirm specificity of shift assay.
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Data analysis
As spontaneous Isc varied between batches of cells,
controls and treatments were carried out on monolayers
from batches of cells plated on the same day and grown
for the same length of time under similar conditions.
Results were analyzed using analysis of variance
(ANOVA) with a post hoc Gabriel’s test or Student’s
nonpaired or paired t tests where applicable. Values are
presented as the mean ± standard error of the mean
(SEM); p values ≤0.05 were considered significant.
Results
Effect of LPS on amiloride-sensitive Isc
We found that an 18-h treatment of H441 cells with 15 µg
ml−1 LPS induced a significant reduction in amiloride-
sensitive Isc from 15.0±2.0 to 8.0±2.0 µA cm
−2 (p=0.01,
n=13) but not amiloride-insensitive currents (Fig. 1a).
Although there was an apparent reduction in resistance of
the monolayers, this did not reach significance (Fig. 1b). We
also noted that the inhibition of Isc with 10 µM amiloride
was slower in cells treated with LPS than in control cells
(Fig. 1c). The effect of LPS on Isc was significantly affected
by treatment time (ANOVA, p<0.01, n=4). A decrease in Isc
was detectable after 4 h and was significantly reduced at
8 and 18 h after treatment with LPS (p<0.05, n=4; Fig. 1d).
We did not observe any acute effects of LPS using continual
Isc measurements over a period of 1 h.
Effect of LPS on IC50 amiloride
The effect of different concentrations of amiloride on
blockade of Isc in cells treated with LPS was investigated.
By constructing a concentration/response curve for both
control and LPS-treated cells, we found that treatment with
LPS significantly shifted the curve to the right. By fitting the
Hill equation to our data, the EC50 for amiloride was
calculated to be 6.8×10−7 M in control cells but significantly
increased to 6.4×10−6 M in LPS-treated cells (p<0.05, n=4;
Fig. 2).
Effect of LPS on channels in apical membrane
Over 90% of all cell-attached patches from the H441 cell
apical membrane contained channels. In 55% of patches
from untreated monolayers (four sets), only constitutively
active cation channel currents that had a mean unitary
amplitude of −0.64±0.03 pA (n=12) at −100 mV and
unitary conductance and reversal potential (Er) values of
about 5 pS and +20 mV, respectively, were displayed
Fig. 3a (i). These properties were similar to those of highly
Na+-selective cation channels (HSC) previously described
in H441 cell monolayers [1]. The remaining 45% of
control cell-attached patches exhibited both spontaneous-
ly active HSCs and cation channel currents with a larger
mean amplitude of −1.77±0.09 pA (n=12) at −100 mV
and unitary conductance and Er values of about 18 pS and
0 mV, respectively. These values were similar to those
previously described for nonselective cation channels
(NSC) in H441 cells (Fig. 3a (ii)). The I/V relationship
Fig. 1 Effect of LPS on short
circuit current (Isc) across H441
cell monolayers. a Spontaneous
Isc before (white bars) and after
the addition of 10 µM amiloride
(black bars) in untreated H441
cells (control) and cells treated
with LPS for 18 h (LPS). Data
are shown as the mean ± SEM.
b Transepithelial resistance (Rt)
of untreated and LPS-treated
H441 cell monolayers. *p<0.05,
significantly different from con-
trol, n=13. c Typical Isc trace
from untreated and LPS-treated
H441 cell monolayers before
and after the application of
amiloride. d Effect of LPS
treatment for 0–18 h on
amiloride-sensitive Isc. Data are
shown as the mean ± SEM.
*p<0.05, significantly different
from control, n=4 (ANOVA,
post hoc Gabriel’s test)
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for HSCs and NSCs and the properties of channel currents
using a patch pipette solution containing the less-permeant
cation NMDG-Cl as the main cation charge carrier have
been previously published [1]. These results indicate that
H441 cell monolayers in the current study expressed
functional constitutively active HSCs and NSCs at a
similar frequency to previous data [1].
Treatment of H441 cells with LPS significantly in-
creased the frequency of patches containing both constitu-
tive HSCs and NSCs to 93% (13 out of 14 patches, p<0.05,
four sets of cell monolayers; Fig. 3b). LPS significantly
increased the NPo of cation channels in patches containing
HSCs and NSCs by ∼100% (n=13, p<0.05) compared to
control patches displaying HSCs and NSCs (Fig. 3c (i)).
Treatment with LPS did not alter unitary conductance or Er
of HSCs or NSCs (data not shown). In addition, treatment
with LPS significantly increased the number of NSC open
Fig. 3 Effect of LPS on constitutive cation channel activity in H441
cell monolayers. a Control cell-attached patches at −100 mV from
H441 cell monolayers contained either only HSCs (55%; i) or both
HSCs and NSCs (45%; ii) with similar properties and at similar
frequencies as previously described (Albert et al. [1]). b Pretreatment
of H441 cell monolayers with 15 µg ml−1 LPS for 18 h increased the
frequency of cell-attached patches containing both HSC and NSC
activity (93%). c Mean data from all cell-attached patches recorded
showing that i LPS significantly increased NPo value of constitutive
channel activity in patches containing both HSC + NSC (n=13, p<0.05)
and ii LPS significantly reduced the number of HSC open levels per
patch in patches containing HSCs (n=13, p<0.05; HSC) but increased
the number of NSC open levels per patch in patches containing both
HSC + NSC (n=13, p<0.01; NSC). d i Inclusion of 1 µM amiloride in
the patch pipette solution had no effect on NSC activity and ii 10 µM
amiloride partially reduced NSC activity in cell-attached patches
at −100 mV. Data are shown as the mean ± SEM. *p<0.05, **p<0.01,
significantly different from the control
Fig. 2 Amiloride sensitivity of control and LPS-treated H441 cells.
Graph of mean percentage inhibition of amiloride-sensitive Isc plotted
against concentration of amiloride for untreated cells (filled squares)
and cells treated with LPS for 18 h (open circles; n=4). Fitting the Hill
equation to the data indicated a shift in the curve to the right and a
change in the EC50 for amiloride from 6.8×10
−7 M in control cells to
6.4×10−6 M in LPS-treated cells
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levels per patch in patches containing HSCs and NSCs by
approximately 300% (n=13, p<0.01) compared to control
patches. However, the number of HSC channel open levels
per patch was significantly reduced by about 50% (n=13,
p<0.05; Fig. 3c (ii)).
To confirm that NSC activity present after LPS
treatment was the same as previously described in
untreated H441 cell monolayers, we investigated the
effect of including the channel blocker amiloride in the
patch pipette solution. Inclusion of 1 µM amiloride had
no effect on NSC activity (n=4; Fig. 3d (i)) although it
abolished HSC activity as previously described (data not
shown; [1]). However, 10 µM amiloride in the patch
pipette solution inhibited NSC activity by 67±11% at
−100 mV (n=4), a value similar to that previously
described in these cells [1] (Fig. 3d (ii)). These results
provide clear evidence that LPS inhibits HSC activity and
increases NSC activity.
Effect of LPS on ENaC mRNA and abundance
To examine if the reduction of amiloride-sensitive current
was mediated by a reduction in functional ENaC channels,
the effect of LPS on mRNA levels was investigated in these
cells. Single mRNA products were labeled with αENaC
and βENaC probes corresponding to the predicted sizes of
these products approximately 3.6 and 2.4 kb, respectively.
Two mRNA products of were determined with the γENaC
probe of approximately 3.4 and 3.6 kb. We observed that
αENaC mRNA abundance was reduced but did not observe
similar changes in βENaC or γENaC mRNA abundance.
These blots were repeated with similar results and the mean
densitometry values of ENaC mRNA/18S ribosomal RNA
are shown (Fig. 4).
Effect of LPS on NF-kB binding activity
Electromobility shift assays indicated that NF-κB protein
(p50/p65) and nuclear extract from H441 cells inhibited the
mobility of a αENaC NF-κB consensus binding sequence
but not a missense sequence of similar length. This effect
was abrogated by preincubation of nuclear protein with
NF-κB p65 or p50 antiserum, indicating that H441 cells
exhibited an endogenous NF-κB binding activity. Treat-
ment with LPS increased NF-κB binding to the αENaC
consensus sequence. The effect of LPS was inhibited by
pretreatment with 5 mM SAS an inhibitor of IkB
phosphorylation (Fig. 5a–c).
Effect of LPS on ERK1/2 and ERK5 phosphorylation
Treatment with LPS induced an increase in phosphory-
lated ERK1/2 and a decrease in phosphorylated ERK5
when compared to β-actin control. Phosphorylated
ERK1/2 proteins were detected after 10 min, reached
maximal levels at 60–120 min (p<0.05, n=3), and
although reduced, were still present after an overnight
treatment with LPS although this did not quite reach
significance (p=0.06, n=3; Fig. 6a, b). Pretreatment of
cells with the MEK1 inhibitor PD98059 (20µM) appeared
to decrease basal ERK1/2 phosphorylation in unstimulated
cells but, because levels were very low, we were unable to
attribute significance to this by densitometry analysis.
However, PD98059 increased levels of phosphorylated
ERK5. Pretreatment with PD98059 inhibited the LPS-
induced phosphorylation of ERK1/2 at 1 and 2 h and
reversed the inhibitory effect of LPS on the phosphoryla-
tion of ERK5 (Fig. 7a, b).
Fig. 4 Effect of LPS on ENaC subunit mRNA expression. a Northern
blot of RNA extracted from untreated control (C) and LPS-treated
(LPS) H441 cells showing labeled mRNA products corresponding to
αENaC (∼3.6 kb), βENaC (∼2.4kb), and γENaC (∼3.4 and ∼3.6 kb).
Corresponding 18S ribosomal RNA blots for each sample are also
shown (18S). Blots were repeated with similar results (n=2)
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Role of NF-kB, ERK1/2, and ERK5 in LPS-mediated
effects on Isc
In these experiments, amiloride-sensitive Isc was reduced to
50±12% of control by LPS alone. After pretreatment with
5 mM SAS (which inhibits IκB kinase and activation of
NF-κB) or CAPE (which inhibits NF-κB translocation to
the nucleus), Isc remained significantly lower than the
control at 51±16% and 63±8%, p<0.05, n=4 and n=3,
respectively (Fig. 8a). However, pretreatment of cells with
20 µM PD98059 prevented the LPS-mediated decrease in
amiloride-sensitive Isc. Levels remained similar to untreated
cells at 98±13% of the control, n=5 (Fig. 8a). There was a
small apparent increase in amiloride-sensitive Isc with
PD98059 alone at 113±11% but this did not reach
significance (n=5). Pretreatment with PD98059 also re-
versed the effect of LPS on the amiloride dose–response
curve returning the EC50 to 7.8×10
−7 (Fig. 8b). These data
imply that activation of ERK1/2 and/or inactivation of
ERK5 are necessary for LPS-mediated inhibition of Isc. The
action of PD98059 alone on Isc is most likely mediated via
phosphorylation of ERK5 or inhibition of endogenous
ERK1/2 phosphorylation (although we were unable to
detect significant changes in ERK1/2 phosphorylation by
PD98059 by Western blotting).
Role of ERK1/2 and ERK5 in LPS-mediated effects
on aENaC protein
Using an N-terminal antiserum that we have previously
shown to recognize EGFP-tagged human αENaC overex-
pressed in H441 cells, we identified a ∼95-kDa protein and
a ∼65-kDa protease-cleaved αENaC protein in total cell
extracts [38, 41]. In addition, we detected a smaller protein
of ∼32 kDa which may also be a product of N-terminal
furin cleavage (Fig. 9a). Consistent with the observations of
others, in apical surface-biotinylated fractions, the ∼65-kDa
protein was predominantly observed, indicating that
αENaC in these cells is also cleaved at the C terminus
[41]. This may have been the result of incubating cells with
fluid on the apical surface; a maneuver thought to activate
protease cleavage [44]. Using a C-terminal antiserum, we
also detected a ∼65-kDa protein in the biotinylated fractions
consistent with N-terminal protease cleavage of αENaC
[23, 44] (Fig. 9b). Taken together, these data are consistent
with the presence of active cleaved proteins in the cell
membrane. Treatment with LPS significantly decreased the
abundance of αENaC proteins in total cell protein fractions
(p<0.05, n=3), and this effect was mimicked in biotiny-
lated fractions using either antiserum (n=3). Pretreatment
with PD98059 prevented the LPS-induced decreased in
αENaC abundance (Fig. 9a–c). No β-actin was detected
in apical biotinylated fractions although it was present in
Fig. 5 Effect of LPS on NF-κB binding activity in H441 cells. a
Typical autoradiograph of an electromobility shift assay using a
double-stranded missense oligonucleotide incubated with nuclear
proteins extracted from control cells (missense) or NF-κB consensus
sequence from the human αENaC promoter incubated with nuclear
proteins extracted from control cells (control) or LPS-treated cells
(LPS) or preincubated with anti-NF-κB p50 antiserum (anti p50) or
p65 antiserum (anti p65) prior to incubation with nuclear protein.
Lanes showing NF-κB consensus sequence incubated with purified
p50+p65 NF-κB protein or no protein are also shown. b Missense
oligonucleotide (missense) or NF-κB consensus sequence from the
human αENaC promoter incubated with nuclear proteins extracted
from control cells (control) or LPS-treated cells (LPS) or cells
pretreated with 5 mM SAS for 30 min prior to treatment with LPS
(LPS+SAS). The position of NF-κB shifted and nonspecific bands are
indicated by arrows. c Graphical representation of data obtained from
three electromobility shift assays quantified using densitometry
analysis. Data are shown as the mean ± SEM. *p<0.05, significantly
different from control
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Fig. 7 Effect of PD98059 on ERK1/2 and ERK5 phosphorylation in
H441 cells. a Typical Western blot of phosphorylated ERK1/2 and
ERK5 in untreated H441 cells (control), after treatment with LPS (LPS),
and after pretreatment with PD98059 for 30 min prior to the addition of
LPS (LPS+PD98059). Protein products of ∼42 and 44 kDa
corresponding to phospho-ERK1 and phospho-ERK2 and ∼110 kDa
corresponding to phospho-ERK5 are indicated by arrows. ERK1/2 and
ERK5 were immunostained using the same blots. Lanes shown in this
figure are from the same Western blot but have been digitally reordered
for clarity. Because of the similarity in size, proteins of 42 kDa
corresponding to β-actin were immunostained in the same samples run
on separate gels to control for loading. b Graphical representation of
data obtained from three sets of Western blots quantified using
densitometry analysis of phosphorylated ERK5/β-actin (filled squares)
and c phosphorylated ERK1/2/β-actin (open squares). Data are shown
as the mean ± SEM. *p<0.05, significantly different from control
Fig. 6 Effect of LPS on ERK1/2 and ERK5 phosphorylation in H441
cells. a Typical Western blot of phosphorylated ERK1/2 (open
squares) and ERK5 (filled squares) in protein extracted from H441
cells treated with LPS (LPS) for 0–360 min and 18 h. Blots were also
immunostained with β-actin as a loading control. Protein products of
42 and 44 kDa corresponding to phospho-ERK1 and phospho-ERK2
and 110 kDa corresponding to ERK5 are indicated by arrows. Proteins
of 42 kDa corresponding to β-actin were also immunostained in all
samples. b Graphical representation of data obtained from three sets of
Western blots quantified using densitometry analysis (phosphorylated
ERK/β-actin). Data are shown as the mean ± SEM. *p<0.05,
significantly different from control
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nonbound fractions from the same samples, showing that
there was no contamination of apical surface membrane
preparations with intracellular protein (Fig. 9c).
Discussion
In this paper, we have investigated the effect of LPS on
transepithelial transport across human H441 airway epithe-
lial cells. H441 cells form monolayers of moderate trans-
epithelial resistance (Rt) of ∼300 Ω in our culture
conditions which is similar to that described for airway
epithelial sheets [24]. LPS significantly decreased sponta-
neous transepithelial short circuit current (Isc) in these cells
and this effect was mediated by a reduction in the
amiloride-sensitive but not the amiloride-insensitive com-
ponent of Isc. The change in Isc was only measurable 4–6 h
post-treatment, inferring that LPS did not acutely modify
the activity of the channels.
In Isc experiments, LPS also increased the EC50
amiloride, indicating that channels in the apical membrane
had a decreased affinity for amiloride. There are two
amiloride-sensitive cation channels in the apical membrane
of H441 cells that contribute to apical Na+ conductance
which have differing sensitivities to amiloride [1]. The HSC
ENaC-like channel is inhibited by <1 µM amiloride, while
the NSC is inhibited by >10 µM amiloride. In control cells,
HSC activity predominated with channels observed in all
patches, whereas NSCs were observed in only 45% of
patches. These data were consistent with our previous
observations and those in rat alveolar type II cells
maintained under similar growth conditions [27]. Thus, in
control cells, HSCs were the main population of channels
contributing to Isc across the monolayer, consistent with the
calculated EC50 amiloride of 0.7 µM. In LPS-treated cells,
HSC activity decreased and NSC activity increased. As
NSCs have a lower affinity for amiloride, their increased
contribution to Isc would explain the LPS induced shift in
EC50 amiloride. Such shifts in channel populations have
previously been described in response to changes in culture
conditions but not in response to LPS [26, 27]. Interestingly,
decreased HSC function correlated with reduced trans-
epithelial Na+ transport and would indicate that HSCs are
the principal route of entry for Na+ across the apical
membrane of H441 cells. Furthermore, while our data
indicate that NSCs also transport Na+, their functional
significance and contribution to Na+ transport in the airway
requires further exploration.
Amiloride-sensitive channels with differing kinetics,
Na+/K+ selectivity, and amiloride sensitivity can be a
product of differential ENaC subunit combinations [16,
17]. In rat ATII cells, the presence of αENaC, βENaC, and
γENaC subunits favored the expression of HSCs with a
low EC50 for amiloride [25], while NSCs were proposed to
be a product of αENaC alone or in dimeric combination
with either βENaC or γENaC [26]. The H441 cells in this
study expressed αENaC, βENaC, and γENaC mRNA and
αENaC protein. We have previously shown that βENaC
and γENaC are also present in the membrane of these cells,
consistent with HSC activity and the low EC50 for
amiloride we observed in control monolayers [33, 44, 47,
49]. Work in Xenopus oocytes showed that αENaC is
necessary to produce functional channels at the cell surface
and that maximal amiloride-sensitive current was achieved
with a αENaC, βENaC, and γENaC combination and
when the α and/or γ subunits are protease cleaved [6, 22,
44]. Our finding that αENaC in the apical membrane was
cleaved and that LPS decreased mRNA and abundance of
cleaved and noncleaved protein would, therefore, support
the observed decrease in the number of functional HSC
Fig. 8 Effect of inhibitors of NF-κB activation and ERK1/2
phosphorylation on LPS-mediated suppression of amiloride-sensitive
Isc. a Amiloride-sensitive Isc was measured by apical application of
10 µM amiloride to monolayers of untreated cells (control) and cells
treated with LPS (LPS) or pretreated with 5 mM SAS (LPS+SAS),
25 µg/ml CAPE (LPS+CAPE), or 20 µM PD98059 (LPS+PD98059)
prior to LPS treatment or PD98059 alone (PD98059). Data are shown
as the mean ± SEM. *p<0.05, significantly different from control.
b Graph of percentage inhibition of amiloride-sensitive Isc plotted
against the concentration of amiloride for untreated cells (filled
squares; n=4) cells treated with LPS (open circles; n=4) or cells
treated with PD98059 prior to the addition of LPS (closed circles; n=3).
Fitting the Hill equation to the data indicated that the EC50 for amiloride
in cells pretreated with PD98059 before LPS treatment was similar to
control cells (∼7×10−7 M)
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channels and reduction in amiloride-sensitive Isc. Similar
findings have been described in alveolar epithelial cells and
distal lung epithelial cells from the fetal rat where LPS
inhibited ENaC mRNA expression and activity [12, 36].
Interestingly, the decreased abundance of αENaC was
inversely related to the frequency of observation and
activity of NSCs. Our interpretation of this result is that
NSCs are unlikely to be a product of αENaC protein. In
support of this notion, previous studies showed that
antisense oligonucleotides to αENaC, βENaC, or γENaC
decreased the observed frequency of HSCs but did not
significantly affect the frequency of NSCs in ATII cells
[27]. The identity of NSCs in H441 cells and how their
observed frequency is increased by LPS, therefore, remains
to be confirmed.
LPS has been shown to act through a number of cell
signaling pathways to modulate gene expression (for a
review, see [19]). We found that LPS increased binding of
NF-κB to a consensus sequence found in the promoter
region of human αENaC. Activation of MAP kinase
pathways, phosphorylation of ERK1/2, and activation of
NF-κB have both been shown to modulate the transcription
and activity of αENaC in lung and renal epithelial cells [4,
11, 32, 45, 48]. Treatment with SAS, an inhibitor of IκB
Fig. 9 Effect of LPS and PD98059 on αENaC protein levels in H441
cells. a Typical Western blot of proteins extracted from untreated
(control), LPS-treated (LPS), and PD98059-pretreated cells (LPS+
PD90859) immunostained with anti-αENaC and anti-β-actin antisera.
Protein products of ∼95, ∼65, and ∼32 kDa corresponding to full-
length and putative protease-cleaved fragments of αENaC using an
N-terminal antiserum and 42 kDa corresponding to β-actin were
immunostained in all samples. Lanes shown in this figure are from the
same Western blot but the last lane has been digitally reordered for
clarity. b Graph of relative abundance of αENaC protein quantified by
densitometry analysis (αENaC/β-actin). *p<0.05, significantly different
to from the control, n=4; †p<0.05, significantly different from cells
pretreated with LPS, n=3. c Western blot of apical surface biotinylated
proteins from untreated (control) or LPS-treated (LPS) H441 cell
monolayers immunostained with N-terminal αENaC antiserum or
C-terminal antiserum. Protein products of ∼65 kDa corresponding to
protease-cleaved αENaC were predominantly detected with either
antiserum. To show that apical biotinylated protein was not contami-
nated with intracellular proteins, blots were washed and reprobed with
anti β-actin monoclonal antiserum. No β-actin was detected in the
apical biotinylated protein samples from the same blot as shown second
from left although residual immunostaining of αENaC is still present.
β-Actin was present in the nonbound fraction from the same samples
run on the same gel. The position of αENaC and β-actin proteins are
indicated by arrows and size markers by lines
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phosphorylation and NF-κB binding activity, prevented
LPS-mediated NF-κB activation but did not reverse the
suppressive effect of LPS on amiloride-sensitive currents in
these cells. In addition, CAPE, which prevents translocation
of NF-κB to the nucleus, had no effect. In support of our
findings, SAS did not reverse TNF-α suppression of
αENaC mRNA levels in type II epithelial cells [15].
LPS has been shown to stimulate both ERK1/2 and ERK
5 in macrophages [51]. We found that LPS induced
phosphorylation of ERK1/2 but decreased phosphorylation
of ERK5. While we cannot rule out any effect of the
treatments on ERK1/2 and ERK5 abundance, few roles for
ERK5 have been described in the lung and the opposing
changes in phosphorylation we have demonstrated infer
that LPS differentially regulates these two kinases in H441
cells. Such differential regulation of ERK5 and ERK1/2 has
been described in other tissues [7, 14] and ERK5 activation
was shown to be enhanced when ERK1/2 signaling was
suppressed in NIH3T3 cells [5]. Consistent with the
findings of Kamakura et al., the MAP kinase inhibitor
PD98059 prevented LPS-induced phosphorylation of ERK
1/2 and the decrease in phosphorylation of ERK5, reversed
the suppressive effect of LPS on amiloride-sensitive Isc,
increased αENaC protein abundance, and restored ami-
loride sensitivity to that of untreated control cells [29].
Taken together, these data infer that inhibition of ERK1/2
phosphorylation and/or increased ERK5 phosphorylation
were, at least in part, important mediators of the LPS
effect on Na+ transport.
We observed that LPS reduced αENaC mRNA and
decreased protein abundance in this study and inhibited
transcriptional activity of the αENaC promoter in A549
lung epithelial cells in a previous study [2]. Both ERK1/2
and ERK5 have been described to mediate changes in gene
transcription in lung cells [42] and there is good evidence
that transcriptional effects as a result of rapid ERK
phosphorylation are maximal several hours later [37, 51].
ERK-sensitive pathways disrupted glucocorticoid trans-
activation of the αENaC promoter in A549 cells [48] and
decreased α-ENaC mRNA expression in rat parotid
epithelial cells [50]. Furthermore, cross-talk between ERK
and cAMP activation of CREB regulated αENaC mRNA
abundance in rat submandibular gland epithelial cells [37].
Thus, we propose that LPS inhibits αENaC mRNA
transcription by the activation of ERK1/2 and inhibition
of ERK5. However, the pathways and the specific roles of
ERK1/2 versus ERK5 in H441 cells remain to be defined.
Direct ERK2 phosphorylation of β and γENaC subunits
has been shown to facilitate their interaction with the
ubiquitin ligase Nedd4, promoting a decrease in functional
channels at the membrane [46]. In addition, activation of
ERK2 by progesterone or a vasopressin-induced factor
(VIP32) downregulated ENaC activity in Xenopus oocytes
via a decrease in channel open probability (Po) [35, 40]. If
LPS activation of ERK1/2 mediated the effects on Po, they
would be expected to precede changes in transcription and
αENaC abundance. As we were unable to demonstrate any
significant functional effects within 4 h, we do not think
this is a likely route of LPS action. We cannot, however,
rule out an action of endogenously active ERK1/2 on
channel Po. Neither do we exclude additional effects of LPS
on mRNA and protein stability or the release of factors
including TNF-α (a proinflammatory cytokine) which has
also been shown to decrease ENaC mRNA and activity in
lung epithelial cells [10, 12].
In conclusion, using a combination of techniques, we
have demonstrated novel effects of LPS applied directly to
human airway epithelial cells. We propose that LPS acts via
ERK signaling pathways to decrease αENaC transcription,
reduce HSC/ENaC channel abundance, activity, and trans-
epithelial Na+ transport in H441 airway epithelial cells.
Such changes could potentially lead to a decrease in net
fluid absorption and contribute to the formation of
pulmonary edema as a result of bacterial infection.
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